ArticleInternational journal of clinical and experimental pathology2018

MiR-361-5p decreases the tumorigenicity of epithelial ovarian cancer cells by targeting at RPL22L1 and c-Met signaling.

Jing Ma et al.PubMed ↗Full text ↗

No numbers read from the abstract.